Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

This study has been completed.

Study NCT00055861 Information provided by National Cancer Institute (NCI)

First Received: March 6, 2003 Last Updated: February 6, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Ramaswamy B, Rhoades CA, Kendra K, et al.: CTEP-sponsored phase II trial of bevacizumab (Avastin) in combination with docetaxel (Taxotere) in metastatic breast cancer. [Abstract] Breast Cancer Research and Treatment 82 (Suppl 1): A-224, S50 2003. Also available online. Last accessed April 22, 2004.